A new vaccine that may be more suitable for preventing pneumococcal disease in people living with HIV has been approved in the United Kingdom. Prevenar 13, manufactured by Pfizer, is targeted at 13 variants of Streptococcus pneumoniae. Recently published research carried out by the Health Protection Agency shows that among people with HIV, these variants

Against a background of fewer diagnoses among heterosexuals infected abroad, the number of gay men diagnosed with HIV in the UK continues to rise, the Health Protection Agency announced today. Moreover, one quarter of them had recently acquired their infection, suggesting a high level of risk taking in this group. The annual epidemiological report also

The number of gay men infected with the sexually transmitted infection lymphogranuloma venereum (LGV) has almost tripled in one year, and the UK now has the world’s worst epidemic of LGV, the Health Protection Agency reported today. At the same time, the agency is tracking an outbreak in gay men

Raltegravir (Isentress)-based treatment appears to have a more favourable impact on fat accumulation and bone metabolism compared to therapy based on a ritonavir-boosted protease inhibitor, according to Spanish research published in the online edition of AIDS. The study involved 74 patients who were taking HIV therapy including a ritonavir-boosted protease inhibitor. Approximately half were

Patients taking antiretroviral therapy have an increased risk of fractures typically associated with low bone mineral density, Danish investigators report in the online edition of AIDS. However, the most important risk factors were the presence of other chronic illnesses and smoking. Treatment with tenofovir (Viread, also in the combination pills Truvada and Atripla) did